Home / Physicians

FOR PHYSICIANS

Comprehensive Molecular
Profiling for Cancer

High-quality molecular insights that help physicians make more informed treatment decisions throughout the cancer care journey

Physicians Tests

Understanding cancer at the molecular level can lead to better treatment options.

Physician Services

Caris healthcare provider services help put precision medicine into practice.

Order Testing

Caris combines the use of tumor profiling technologies with capabilities in ways only we can.

Molecular Profiling for Cancer Therapy Selection

Tissue Profiling

Comprehensive analysis of tumor tissue.

Blood Profiling

Advanced liquid biopsy and monitoring.

Molecular AI

Proprietary AI interprets complex molecular data.

Treatment Insights

Actionable biomarkers and therapy matching.

Clinical Action

Guiding precise, individualized decisions.

High quality molecular information to guide precise and individualized treatment decisions.

Caris helps improve the lives of thousands of patients each day through the analysis of DNA and RNA by whole exome and whole transcriptome sequencing (WES/WTS) in tissue or blood, plus immunohistochemistry (IHC) of key proteins in tissue specimens. Caris also provides clinically validated AI algorithms to help with therapy selection in cases of metastatic colorectal cancer and cancer of unknown primary.

Tumor Tissue Sample

MI Cancer Seek®

Comprehensive molecular insights that help clarify diagnosis, guide treatment decisions, and support better outcomes for patients.

The first and only simultaneous WES/WTS-based assay with CDx indications for adult and pediatric patients (ages 1+).

Tumor Tissue Sample

Caris MI Clarity™

AI-powered prognostic test for HR+/HER2- early-stage breast cancer.

Analyzes digitized H&E whole slide images combined with clinical inputs to stratify patients into low- and high-risk categories for both early (Years 0–5) and late (Years 5–15) distant recurrence

Blood Sample

Caris Assure®

Whole Blood. Whole Picture.

Caris Assure is the only liquid biopsy that analyzes both plasma and buffy coat variants, providing a more complete molecular profile.

Blood / Bone Marrow

Caris ChromoSeq™

Comprehensive genomic analysis for myeloid malignancies designed to replace conventional karyotyping, FISH, and NGS workflows.

Myeloid malignancies are complex. Genetic testing shouldn’t be. Caris ChromoSeqTM, a whole-genome sequencing assay, brings the complete molecular picture into a single test, supporting more confident diagnosis, risk stratification, and treatment decisions in myeloid malignancies.

Tumor Tissue Sample

MI Profile®

Comprehensive molecular profiling that helps guide precise and individualized treatment decisions.

Assessment of DNA, RNA and Proteins from tumor tissue to reveal a more complete molecular blueprint for clinicians to assess next steps forward in a patient’s care.

Available globally
*Excluding United States of America, EEA, EU and CH countries

Tumor Tissue Sample

MI Tumor Seek Hybrid™

One assay that provides a comprehensive molecular blueprint that saves tissue without compromising results.

A laboratory developed test (LDT) that simultaneously captures both DNA and RNA in one assay. Results also include AI signatures to help confirm diagnosis and improve therapy selection.

Available globally
*Excluding United States of America, EEA, EU and CH countries